Family Medicine

Medicine & Life Sciences

1. 1-O-decylpropanediyl-3-phosphorylcholine 12%
2. Alaska Natives 33%
3. Ambulatory Care 16%
4. Anti-Bacterial Agents 77%
5. Anticonvulsants 55%
6. Antimicrobial Stewardship 85%
7. Antiviral Agents 50%
8. Birthing Centers 31%
9. Centers for Disease Control and Prevention (U.S.) 20%
10. Cephalosporin Resistance 31%
11. Clinical Competence 17%
12. Clinical Trials 38%
13. Communicable Diseases 20%
14. Delivery of Health Care 46%
15. Demography 34%
16. Disease Progression 15%
17. Drug Hypersensitivity 11%
18. Duration of Therapy 23%
19. Elderly 11%
20. Emergencies 11%
21. Exanthema 16%
22. Foreskin 78%
23. Gastroesophageal Reflux 20%
24. Global Health 57%
25. Gonorrhea 23%
26. Guidelines 61%
27. Health 10%
28. Health Education 19%
29. Health Services 14%
30. Health Services Accessibility 23%
31. Hematologic Diseases 23%
32. Hepacivirus 84%
33. Hepatitis B 19%
34. Hepatitis B virus 19%
35. HIV 27%
36. Hypersensitivity 55%
37. Infections 17%
38. Inpatients 13%
39. Insurance Benefits 61%
40. Interviews 11%
41. Learning 10%
42. Librarians 10%
43. Literacy 70%
44. Medical Students 58%
45. Medication Errors 10%
46. Medication Reconciliation 38%
47. Medicine 58%
48. Meta-Analysis 44%
49. Mothers 12%
50. Musculoskeletal Pain 24%
51. Neoplasm Metastasis 36%
52. Newborn Infant 15%
53. North American Indians 87%
54. Optic Disk 65%
55. Osteopathic Medicine 24%
56. Parents 44%
57. Patient Discharge 28%
58. Patient Education 14%
59. Patient Safety 16%
60. Patient Transfer 100%
61. Pediatrics 38%
62. Penis 67%
63. Pharmaceutical Preparations 10%
64. Pharmacists 58%
65. Phenytoin 48%
66. Physicians 23%
67. Population 13%
68. Population Groups 61%
69. Prescriptions 49%
70. Primary Health Care 64%
71. Publication Bias 25%
72. PubMed 11%
73. Quality Improvement 16%
74. Registries 46%
75. Religion 68%
76. Respiratory Tract Infections 18%
77. Retrospective Studies 39%
78. Ribavirin 12%
79. Safe Sex 27%
80. Sexual Health 69%
81. Sexually Transmitted Diseases 58%
82. Siblings 54%
83. Skilled Nursing Facilities 11%
84. Skin 32%
85. Sofosbuvir 15%
86. Software 11%
87. Statistics 45%
88. Stevens-Johnson Syndrome 11%
89. Students 55%
90. Substance-Related Disorders 14%
91. Sustained Virologic Response 80%
92. Systematic Reviews 43%
93. Teaching 13%
94. Telemedicine 65%
95. Therapeutics 21%
96. Uganda 70%
97. Urologists 68%
98. Vaccination 47%
99. Virus Diseases 18%
100. Vulnerable Populations 11%